COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,036 Articles (22,627 medRxiv, 8,409 bioRxiv)

Most recent first Previous |  Page 1989: Articles 19881-19890  | Next

Associations between vaping and Covid-19: cross-sectional findings from the HEBECO study
Kale, D., Herbec, A., Perski, O., Jackson, S. E., Brown, J., Shahab, L.
10.1101/2020.12.01.20241760 — Posted: 2020-12-03
Variants in SARS-CoV-2 Associated with Mild or Severe Outcome
Voss, J. D., Skarzynski, M., McAuley, E. M., Maier, E. J., Gibbons, T. F., Fries, A. C., Chapleau, R. R.
10.1101/2020.12.01.20242149 — Posted: 2020-12-03 Discussion: Offsite
The COVID-19 herd immunity threshold is not low: A re-analysis of European data from spring of 2020
Fox, S. J., Potu, P., Srinivasan, R., Lachmann, M., Meyers, L. A.
10.1101/2020.12.01.20242289 — Posted: 2020-12-03
Prediction of Covid-19 spreading and optimal coordination of counter-measures: From microscopic to macroscopic models to Pareto fronts
Wulkow, H., Conrad, T., Djurdjevac Conrad, N., Mueller, S. A., Nagel, K., Schuette, C.
10.1101/2020.12.01.20241885 — Posted: 2020-12-03
Implications of delayed reopening in controlling the COVID-19 surge in Southern and West-Central USA
Abhijit Dandekar, R., Wang, E., Barbastathis, G., Rackauckas, C.
10.1101/2020.12.01.20242172 — Posted: 2020-12-03
Extrapolation of United Kingdom Pillar 2 Care home Covid-19 test data to ascertain effectiveness of lateral flow testing in low prevalence settings
Richter, A., Best, A., Mirza, J., Percival, B., Mayhew, M., Megram, O., Ashford, F., White, T., Moles-Garcia, E., Plant, T., Bosworth, A., Kidd, M., McNally, A.
10.1101/2020.12.01.20237784 — Posted: 2020-12-03 Discussion: Onsite
A Bayesian Susceptible-Infectious-Hospitalized-Ventilated-Recovered Model to Predict Demand for COVID-19 Inpatient Care in a Large Healthcare System
Self, S. C. W., Huang, R., Amin, S., Ewing, J. A., Rudisill, C., McLain, A.
10.1101/2020.12.01.20241984 — Posted: 2020-12-03
Diagnosis of SARS-CoV-2 infections in times of material shortage
Lucas Sandri, T., Inoue, J., Geiger, J., Griesbaum, J. M., Heinzel, C., Burnet, M., Fendel, R., Kremsner, P. G., Held, J., Kreidenweiss, A.
10.1101/2020.12.01.20242008 — Posted: 2020-12-03
A Novel COVID-19 Early Warning Tool: Moore Swab Method for Wastewater Surveillance at an Institutional Level
Liu, P., Ibaraki, M., VanTassell, J., Geith, K., Cavallo, M., Kann, R., Moe, C.
10.1101/2020.12.01.20238006 — Posted: 2020-12-03 Discussion: Onsite
Sewage, Salt, Silica and SARS-CoV-2 (4S): An economical kit-free method for direct capture of SARS-CoV-2 RNA from wastewater.
Whitney, O. N., Kennedy, L. C., Fan, V., Hinkle, A., Kantor, R., Greenwald, H., Crits-Christoph, A., Al-Shayeb, B., Chaplin, M., Maurer, A. C., Tjian, R., Nelson, K. L.
10.1101/2020.12.01.20242131 — Posted: 2020-12-03 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).